◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › E › EW

Edwards Lifesciences Corp (EW) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · Health Care Equipment · DATA UPDATED 2026-09-13

Edwards Lifesciences Corp (EW) operates in the Health Care Equipment industry and is headquartered in Irvine, United States with about 16,000 employees. Its market capitalization is roughly $51 billion. In the fiscal year ended 2025-12-31, EW reported $6.1B in revenue and $1.1B in net income.

Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.

Interactive charts & full statements → Open the EW valuation workbench →

EW Revenue & Earnings History — Annual Income Statement

Income statement	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Revenue	$6.5B	$6.1B	$5.4B	$6.0B	$5.4B	$5.2B	$4.4B	$4.3B	$3.7B	$3.4B	$3.0B	$2.5B	$2.3B	$2.0B	$1.9B	$1.7B	$1.4B	$1.3B	$1.2B	$1.1B	$1.0B
Gross Profit	$5.1B	$4.7B	$4.3B	$4.6B	$4.2B	$4.0B	$3.3B	$3.2B	$2.8B	$2.6B	$2.2B	$1.8B	$1.7B	$1.5B	$1.4B	$1.2B	$1.0B	$922M	$829M	$710M	$654M
Gross Margin %	78.0%	78.1%	79.5%	77.0%	78.3%	76.6%	74.9%	73.4%	75.2%	74.3%	72.8%	72.6%	72.8%	73.4%	73.3%	72.5%	71.7%	69.8%	67.0%	65.0%	63.0%
Operating Income (EBIT)	$1.8B	$1.6B	$1.4B	$1.5B	$1.7B	$1.6B	$1.3B	$1.2B	$1.1B	$1.0B	$816M	$576M	$487M	$433M	$397M	$329M	$282M	$238M	$209M	$170M	$164M
Operating Margin %	28.1%	27.0%	25.4%	25.6%	31.6%	30.8%	29.5%	27.6%	29.3%	29.4%	27.5%	23.1%	21.0%	21.2%	20.9%	19.6%	19.5%	18.0%	16.9%	15.5%	15.8%
Net Income	$1.0B	$1.1B	$4.2B	$1.4B	$1.5B	$1.5B	$823M	$1.0B	$722M	$622M	$570M	$495M	$811M	$392M	$293M	$237M	$218M	$229M	$129M	$113M	$130M
Net Margin %	15.4%	17.7%	76.8%	23.4%	28.3%	28.7%	18.8%	24.1%	19.4%	18.1%	19.2%	19.9%	34.9%	19.1%	15.4%	14.1%	15.1%	17.3%	10.4%	10.4%	12.6%
EBITDA	$1.5B	$1.4B	$1.7B	$1.5B	$2.0B	$1.9B	$1.1B	$1.3B	$872M	$1.1B	$827M	$707M	$1.2B	$590M	$453M	$345M	$327M	$297M	$227M	$214M	$240M
Earnings Per Share (EPS)	$1.73	$1.83	$6.97	$2.30	$2.44	$2.38	$1.30	$1.64	$1.13	$0.96	$0.87	$0.75	$1.25	$0.57	$0.41	$0.33	$0.30	$0.33	$0.18	$0.15	$0.17
Shares Outstanding (M)	578M	586M	599M	609M	624M	631M	632M	637M	641M	648M	653M	661M	651M	683M	710M	716M	715M	704M	715M	752M	767M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EW Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Total Revenue	$1.7B	$1.6B	$1.6B	$1.6B	$1.5B	$1.4B	$1.4B	$1.4B
Gross Profit	$1.4B	$1.3B	$1.2B	$1.2B	$1.2B	$1.1B	$1.1B	$1.1B
Gross Margin %	77.6%	78.2%	78.3%	77.9%	77.6%	78.6%	78.9%	80.6%
Operating Income (EBIT)	$520M	$515M	$370M	$425M	$431M	$395M	$313M	$351M
Operating Margin %	29.8%	31.2%	23.6%	27.4%	28.1%	28.0%	22.6%	25.9%
Net Income	$242M	$381M	$91M	$291M	$330M	$358M	$386M	$3.1B
Net Margin %	13.9%	23.1%	5.8%	18.7%	21.5%	25.3%	27.8%	226.7%
EBITDA	$520M	$500M	$133M	$388M	$400M	$470M	$484M	$429M
Earnings Per Share (EPS)	$0.42	$0.66	$0.16	$0.50	$0.56	$0.61	$0.65	$5.13
Shares Outstanding (M)	578M	581M	582M	586M	588M	588M	590M	598M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EW Free Cash Flow History

Cash flow	TTM → 2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Cash from Operations (CFO)	$1.7B	$1.6B	$542M	$896M	$1.2B	$1.7B	$1.1B	$1.2B	$927M	$1.0B	$704M	$550M	$1.0B	$473M	$374M	$314M	$251M	$165M	$153M	$210M	$231M
Capital Expenditures (CapEx)	$287M	$260M	$252M	$266M	$265M	$330M	$407M	$278M	$242M	$176M	$217M	$106M	$94M	$110M	$128M	$91M	$63M	$64M	$78M	$62M	$59M
Free Cash Flow (FCF)	$1.4B	$1.3B	$290M	$630M	$953M	$1.4B	$647M	$901M	$685M	$825M	$487M	$443M	$929M	$363M	$246M	$224M	$188M	$101M	$75M	$148M	$171M
FCF Margin %	22.0%	22.0%	5.3%	10.5%	17.7%	26.8%	14.8%	20.7%	18.4%	24.0%	16.4%	17.8%	40.0%	17.7%	13.0%	13.3%	13.0%	7.7%	6.1%	13.5%	16.5%
Dividends Paid	—	—	—	$170M	$146M	$159M	$140M	$19M	$688M	$0M	$254M	$31M	$226M	$1.3B	$407M	$526M	$254M	$129M	$206M	—	—

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EW Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30
Cash from Operations (CFO)	$652M	$44M	$451M	$574M	$290M	$280M	$280M	$352M
Capital Expenditures (CapEx)	$67M	$65M	$97M	$58M	$49M	$56M	$56M	$32M
Free Cash Flow (FCF)	$585M	($21M)	$354M	$516M	$241M	$224M	$224M	$320M
FCF Margin %	33.6%	-1.3%	22.5%	33.2%	15.7%	15.9%	16.2%	23.6%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EW Balance Sheet History

Balance sheet	2026-06-30	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31	2020-12-31	2019-12-31	2018-12-31	2017-12-31	2016-12-31	2015-12-31	2014-12-31	2013-12-31	2012-12-31	2011-12-31	2010-12-31	2009-12-31	2008-12-31	2007-12-31	2006-12-31
Total Assets	$13.9B	$13.7B	$13.1B	$9.4B	$8.3B	$8.5B	$7.2B	$6.5B	$5.3B	$5.7B	$4.5B	$4.1B	$3.5B	$2.7B	$2.2B	$2.0B	$1.8B	$1.6B	$1.4B	$1.3B	$1.2B
Cash & Cash Equivalents	$2.9B	$2.9B	$3.0B	$1.1B	$769M	$863M	$1.2B	$1.2B	$714M	$818M	$930M	$718M	$654M	$420M	$311M	$171M	$396M	$334M	$219M	$142M	$183M
Total Liabilities	$3.1B	$3.4B	$3.0B	$2.6B	$2.5B	$2.7B	$2.7B	$2.3B	$2.2B	$2.7B	$1.9B	$1.6B	$1.3B	$1.2B	$742M	$643M	$459M	$458M	$521M	$510M	$497M
Total Debt (Short + Long-Term)	$623M	$623M	$621M	$620M	$622M	$621M	$622M	$620M	$594M	$1.0B	$1.6B	$1.2B	$1.2B	$593M	$189M	$150M	$42M	$90M	$176M	$212M	$236M
Total Shareholders' Equity	$10.6B	$10.3B	$10.0B	$6.7B	$5.8B	$5.8B	$4.6B	$4.1B	$3.1B	$3.0B	$2.6B	$2.5B	$2.2B	$1.6B	$1.5B	$1.3B	$1.3B	$1.2B	$879M	$835M	$749M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EW viewer.

EW Metric Deep Dives

Other Companies in Health Care Equipment

ISRG · Intuitive Surgical — $141 billion
MDT · Medtronic — $118 billion
SYK · Stryker Corporation — $106 billion
BSX · Boston Scientific — $63 billion
BDX · Becton Dickinson — $49 billion
IDXX · Idexx Laboratories — $40 billion
DXCM · Dexcom — $34 billion
RMD · ResMed — $32 billion

This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी

← EVYM All “E” companies EWA →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.